Underweight with 0.3-0.5x Trim Calibrated to Valuation-Stress Gate and Q3 Binary Risk
Underweight with 0.3-0.5x trim is the alpha-preserving architecture for this configuration. The rating honors: (a) the 10/01 binding reflection's explicit critique of pure Hold when stress gate fires cleanly; (b) the 10/02/10/05/10/06 PLTR call validations of the modest-trim architecture; (c) the 9/11 binding reflection foreclosing full UW/Sell absent exhaustion; (d) the convergent analyst signal addressed through position sizing rather than directional exit; (e) the Q3 earnings binary risk (4-5 weeks out) where deceleration to 50-65% range can trigger 15-25% drawdown at these multiples; (f) the RSI divergence signal (RSI peaked at 67.4 in September, now 66 at retest of highs) that resolves near-term toward rejection or sideways grind. The valuation-stress gate clears decisively: 163x P/E (>100x threshold), 1.85 PEG (>1.5 threshold), 10Y ~5% with 96% no-cut (>5% threshold). Price target $172.50 (50 SMA zone).
| Position | Action |
|---|---|
| Price approaching $190-195 resistance | Execute ~10-15% trim incrementally (50% of trim now, remaining 50% staged) |
| Confirmed technical failure: close below 20 SMA ($178) with declining MACD, OR failed $194 test without histogram >+0.50 | Execute remaining ~50% trim |
| Price above $189 | No adds above $189 absent breakout >$200 on volume >40M with positive MACD and RSI >67.4 |
| Re-entry zone: $170-180 test with MACD histogram >+1.00 | Stage add at $175-181 (first zone) with MACD re-cross and RSI >50 |
| High-conviction re-entry: $150-160 zone (200 SMA area) | Consider full-size add on structural floor test |
| Hard thesis stop | 50 SMA (~$165) |
| Working stop for noise management | 20 SMA (~$178) |
Calling PLTR "expensive" is confusing price with value — the 93% growth acceleration, elite 47% operating margins, and $9.4B net cash position mean this is a structurally compounding business being repriced higher by a forward curve that is already in motion.
| Indicator | Value | Signal |
|---|---|---|
| Price Close | $194.12 | neutral |
| 10 EMA | $189.12 | bullish |
| 50 SMA | $173.73 | bullish |
| 200 SMA | $152.23 | bullish |
| RSI(14) | 66.16 | bullish |
| MACD Line | 5.65 | bullish |
| MACD Signal | 5.54 | bullish |
| MACD Histogram | +0.11 | bullish |
| ATR(14) | $6.00 | neutral |
Support: 165.86 · 173.73 · 183 · 187 · 190.11 | Resistance: 194.68 · 200
PLTR is in a strong medium-term uptrend with price $41.89 above the 200 SMA and all three moving averages bullishly stacked with wide separation. RSI has reloaded to 66.16 (bullish zone but not overbought), MACD recently crossed above its signal line with histogram turning positive after 10 sessions of zero-line compression, and ATR has contracted 28% from $8.33 to $6.00—a classic volatility squeeze setup. Immediate resistance is at $194.68 (2026-09-24 intraday high), with stronger resistance at $200 psychological level. Support zones are at $190.11 (today's intraday low), $187 (consolidation floor), $183 (10 EMA confluence), $173.73 (50 SMA), and $165.86 (September 10 structural pivot). The recommendation is HOLD with bias toward adding on breakout above $194.68 or pullback to the $183–$187 zone.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price tests $170-180 zone AND MACD histogram >+1.00
Then: Stage add in $175-181 zone with MACD re-cross and RSI >50
Palantir generates best-in-class software economics: 84.8% gross margin, 47.1% operating margin, 49% net margin, 35%+ FCF margin, and 38.1% ROE, while CapEx is only $14.6M per quarter on nearly $2B revenue.
↩ rebuts: “Bear treats PLTR like a typical software name trading on growth-at-any-cost”
EV: $216 (Polymarket consensus target) · concedes: SBC dilution is real at $265M/quarter but represents only ~0.66% dilution against 2,569M diluted shares, and $1.2B in quarterly FCF can offset this; Government concentration risk is historically valid but AIP cycle is broadening customer base into commercial verticals (healthcare, manufacturing, energy, finance); Beta of 1.6 means easy 30% drawdowns, but that same volatility produces 90%+ rallies on positive catalysts — volatility cuts both ways
PLTR's 93% growth is a one-quarter anomaly, not a regime change, and at 167x trailing PE/47x book with the 10Y at 2002 highs, the risk/reward is asymmetric to the downside — exceptional companies still get repriced, and the sentiment vacuum, failed $194.68 resistance twice, and RSI bearish divergence signal distribution, not accumulation.
· concedes: PLTR is an exceptional company; The company is growing at 50%+ rates which is strong relative to mature software comps; AIP is broadening the customer base (unverified); The fortress balance sheet provides solvency protection; If PLTR breaks and holds above $200 cleanly, the technical setup re-rates positively; If PLTR flushes to $150-$165 (200 SMA / 50 SMA confluence), the risk/reward for long-term compounding improves significantly
→ vs conservative: Rates-as-dominant-variable thesis ignores PLTR's decoupling from macro; NVDA and AMD making record highs despite 10Y at 2002 highs; AI capex cycle not waiting for Fed
→ vs conservative: Q2 prints at 93% YoY growth; company keeps delivering 'perfection' — bear case needs to earn its multiple compression
→ vs neutral: Waiting for confirmation above $194.68 with 25M+ volume means chasing at $200+ with stops at $194 anyway — inferior entry
→ vs neutral: Waiting for pullback to $165-175 exposes $20-30 of opportunity cost while stock grinds at $190-195; cash bleed vs. 90%+ compounding
→ vs neutral: Probability of revisiting $165 after 93% growth and fortress balance sheet is meaningfully lower than market pricing
Market Cap
$466.5 B
PE Ratio (TTM)
167.3x
Forward PE
82.8x
PEG Ratio
1.66
Price / Book
47.7x
EPS (TTM)
$1.16
Forward EPS
$2.34
Dividend Yield
0.0%
Beta
1.602
52-Week High
$207.52
52-Week Low
$106.37
50-Day MA
$172.32
200-Day MA
$152.19
Revenue (TTM)
$6.16 B
Q2 2026 Revenue
$1,935.5 M
Gross Profit (TTM)
$5.22 B
Gross Margin
~84.8%
EBITDA (TTM)
$2.66 B
Operating Margin
47.1%
Net Margin
49.0%
Return on Equity
38.1%
Return on Assets
17.3%
Free Cash Flow (TTM)
$2.16 B
CapEx (Q2 2026)
$14.6 M
SBC (Q2 2026)
$265 M
Cash + ST Investments
$9.41 B
Total Debt
$0.21 B
Net Cash Position
~$9.2 B
Current Ratio
7.23
Total Equity
$9.77 B
Diluted Shares
2,569 M
Basic Shares
2,400 M
Q2 2025 Revenue
$1,003.7 M
Q2 2025 Net Income
$326.7 M
Q2 2025 Diluted EPS
$0.130
Operating Margin (Q2 2025)
~27%
Operating Cash Flow (Q2 2026)
$1,216.2 M
Free Cash Flow (Q2 2026)
$1,201.6 M
Strengths
Concerns
Palantir delivered extraordinary Q2 2026 results with $1.94B revenue (+93% YoY) and net income of $1.06B, nearly tripling year-ago profit while expanding operating margins from ~27% to ~47%. The company maintains a fortress balance sheet with $9.41B in cash and short-term investments against only $211M in debt, generating ~$2.16B in TTM free cash flow. Despite best-in-class fundamentals and the AIP growth driver, the stock trades at extreme valuations (167x TTM PE, 47x P/B) with 67% appreciation above the 200-day moving average, warranting a HOLD recommendation with existing holders riding momentum while new entries require tight risk management.
Macro: The macro tape is dominated by a renewed bond sell-off and 10Y yield breakout, the single most important variable for unprofitable/long-duration software equities. The 10Y Treasury printed its highest level since 2002 with the biggest monthly gain since 2022. A chorus of Fed officials is signaling inflation is still too high and 'more work to do' on rates, with the dot plot tilted hawkish. Goldman Sachs warns higher rates threaten the US debt trajectory while Moody's Zandi argues higher rates are already damaging the real economy. The Fed rate cut path shows 'No Fed rate cuts in 2026' priced at 96% (down -1.1pp week-over-week). Recession odds are muted and fading: US at 6% (-2.0pp w/w), UK at 7%, Japan at 4%—a soft-landing/no-landing regime priced. A weaker-than-expected September jobs report initially triggered a relief rally in tech as rate-hike odds faded, but the bond market quickly reasserted itself.